The largest database of trusted experimental protocols
Sourced in United States

The PCS-100-020™ is a laboratory equipment product offered by American Type Culture Collection. It is designed for use in cell culture applications. The core function of the PCS-100-020™ is to provide a controlled environment for the growth and maintenance of cell cultures.

Automatically generated - may contain errors

8 protocols using pcs 100 020

1

Primary Coronary Endothelial Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary coronary artery endothelial cells (HCAECs) were purchased from (ATCC® PCS-100-020™). Cells were cultured according to the instructions provided by ATCC. Serum was not added into the medium in cases of drug treatment. Cells were harvest during logarithmic growth phase for subsequent experiments.
+ Open protocol
+ Expand
2

Detecting Physiological Differences in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four experiments were needed to detect a physiologically relevant difference of 25% between control and intervention, given a standard deviation of 10%, a power of 80%, and an α of 0.05. Data are presented as mean ± standard deviation (SD). The distribution of the data was tested using the Shapiro-Wilk test. Normal distributed data were tested by one-way ANOVA with Bonferroni post hoc testing or by a Student’s t test. Non-normally distributed data were tested with Kruskal-Wallis and Mann-Whitney U test with Bonferroni correction. In each experiment, we attempted to avoid experimental bias by single-well use by pooling two wells with cells. The number of experiments mentioned in the figures refers to the number of technical replicates with cells from two donors (PCS-100-020 from ATCC, LOT# 59885589 and C-12221 from PromoCell, LOT# 425Z0191.1). Graphs were created in Graphpad Prism 8 and statistical analysis was performed using IBM SPSS Statistics 25. The cut-off values for statistical significance were indicated in the figures by *, **, and *** for p < 0.05, p < 0.01, and p < 0.001, respectively.
+ Open protocol
+ Expand
3

Culturing Human Coronary Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary coronary artery endothelial cells (HCAEC) were obtained from ATCC (ATCC® PCS-100-020™). Cells culture was performed according to ATCC protocol. Serum-free culture medium was used in drug treatment. Cells were collected during logarithmic growth phase for subsequent experiments.
+ Open protocol
+ Expand
4

Modeling Cardiomyocyte Injury and Protection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human coronary artery endothelial cells (HCAECs; PCS-100-020™, ATCC, Manassas, VA, USA) were cultured in Vascular Cell Basal Medium (ATCC) with 5 ng/ml VEGF, 5 ng/ml EGF, 5 ng/ml FGF, 15 ng/ml IGF-1, 10 mM L-glutamine, 0.75 U/ml heparin sulfate, 1 µg/ml hydrocortisone, 50 µg/ml ascorbic acid, 1% amphotericin B, 1% penicillin-streptomycin, and 10% FBS. Hypoxia-reoxygenation (H/R) injury was induced on cultured cells as described in our previous study 15 (link). In brief, hypoxic stress was induced in a tri-gas incubator with an N2 concentration of 95% and a CO2 concentration of 5% for 45 min. Then, cells were cultured under normal oxygen concentration for 2 h. Dapagliflozin (10 μM) was applied to HCAECs 24 h before H/R injury in vitro. BAPTA (50 μM; #A1076, Sigma-Aldrich, Burlington, MA, USA) was added to the medium for 30 min to attenuate intracellular calcium overload. Ionomycin (100 μM; #200-664-3, Sigma) was alternatively applied for 30 min to induce calcium overload. To inhibit F-actin degradation, HCAECs were treated with jasplakinolide (Jas, 2 μM; #ab141409. Abcam) over 2 h before H/R. To induce an oxidative stress microenvironment, HCAECs were treated with 0.3 mM hydrogen peroxide for 6 h. To prevent CaMKII activation, HCAECs were incubated with KN93 (5 μM; #S678, Selleck Chem. LLC, Houston, TX, USA) during 2 h before H/R.
+ Open protocol
+ Expand
5

Culturing Primary Human Coronary Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary coronary artery endothelial cells (HCAEC) were purchased from ATCC (ATCC® PCS-100-020™) and were cultured in strict accordance with the instructions provided by ATCC. Cells were harvested during the logarithmic growth phase for subsequent experiments.
+ Open protocol
+ Expand
6

Evaluating Endothelial Permeability with DOX and RXRA Agonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary HCAECs were purchased from the American Type Culture Collection (PCS-100-020) and cultured in vascular cell base medium (PCS-100-030) containing an endothelial cell growth kit (PCS-100-041) at 37°C. HCAECs at the fourth or fifth passage were used for DOX treatment. Culture medium containing DOX and isotretinoin or bexarotene was added together. All cells were harvested at 12 or 24 hours after DOX treatment.
For permeability assay, HCAECs were seeded at 1.5-fold of the confluent concentration on a ThinCert 0.4-μm translucent insert (Greiner) placed on a 24-well plate and grew for 48 hours. Cells were treated with DOX and RXRA agonists for another 24 hours. Medium in both the insert and outer wells were refreshed, and FITC (1 μg/μl) (4 kDa; Sigma-Aldrich) was added to the insert for 30-min incubation. Two hundred microliters of medium from the outer well was then used to quantify the FITC concentration using a microplate reader (Bio-Rad) at 490 nm.
+ Open protocol
+ Expand
7

Endothelial and Smooth Muscle Cells Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endothelial cells (ECs; CRL-1730), smooth muscle cells (SMCs; CRL-1999) and human coronary artery endothelial cells (HCAECs; PCS-100020) were obtained from the American Type Culture Collection (Manassas, VA, USA). ECs, SMCs and HCAECs were cultured with Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum at 37 °C in a 5% CO2 incubator.
The cells were seeded in a six-well plate for 24 h before transfection. When the cell confluence had reached about 50%, ECs, SMCs and HCAECs were transfected following the instructions of the lipofectamine 2000 reagents (Invitrogen Inc., Carlsbad, CA, USA). At 24 h after transfection, the cells were exposed to 50 μg/mL oxidized-low-density lipoprotein (ox-LDL) (Beijing Xiesheng Bio-Technology Limited, Beijing, China) for 24 h, or continued normal incubation [21] (link).
LncRNA HIF1A-AS2-specific small interfering RNA (siRNAs) including si-HIF1A-AS2-1 (sense AAGAGAUCUGUGGCUCAGUUCCUUU and antisense AAAGGAACUGAGCCACAGAUCUCUU) and si-HIF1A-AS2-2 (sense GAGUUGGAGGUGUUGAAGCAAAUAU and antisense AUAUUUGCUUCAACACCUCCAACUC), si-NC, overexpression plasmids including oe-USF1 (pcDNA3.1-USF1) and oe-ATF2 (pcDNA3.1-ATF2) as well as oe-NC (pcDNA3.1-NC) were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China).
+ Open protocol
+ Expand
8

Hypoxia-Reoxygenation Injury Model in HCAECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCAECs (American Type Culture Collection, PCS-100-020™) were cultured with vascular basal cell medium containing 5 ng/mL vascular endothelial growth factor, 5 ng/mL epidermal growth factor, 5 ng/mL fibroblastic growth factor, 15 ng/mL insulin-like growth factor 1, 10 mM L-glutamine, 0.75 U/mL heparin sulfate, 1 µg/mL hydrocortisone, 50 µg/mL ascorbic acid, 1% amphotericin B, 1% penicillin-streptomycin and 10% fetal bovine serum. Hypoxia/reoxygenation was used to induce sI/R injury in vitro. In brief, the medium was changed to an ischemia-mimicking solution containing 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10 mM 2-deoxy-D-glucose, 139 mM NaCl, 12 mM KCl, 0.5 mM MgCl2, 1.3 mM CaCl2 and 20 mM lactic acid, pH 6.2, and then the cells were incubated under 100% nitrogen (O2 < 1%) at 37 °C for 45 min. The cultures were then returned to normal culture conditions (10% fetal bovine serum, 37 °C ambient air, 5% CO2) for 2 h. Empagliflozin (10 µM) was added to the HCAECs 12 h before the sI/R injury. For the induction of oxidative stress, HCAECs were treated with 0.3 mM hydrogen peroxide for six hours. NAC (10 mM) was added to the medium of HCAECs to reduce oxidative stress-induced DNA-PKcs activation in the presence of sI/R, based on a previous study [42 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!